Materiality
72
company update
Source
External coverage
Decided
2026-05-10
Agenus says its Zydus manufacturing deal has closed, France access has expanded, and the Phase 3 BATMAN program is nearing launch. The payload reads as constructive for AGEN because it combines operational execution with a clinical catalyst, but the evidence is limited to a news summary/title.
View event details1 more curated